V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210034949 | 210012011 | null | 102.6 | Curative (C) | 2016-12-10 | 2017-05-14 | Blinatumomab | Y | N | 210032638 | BLINATUMOMAB |
| 210034950 | 210012019 | 0.85 | 70 | Curative (C) | 2014-11-27 | 2014-11-27 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | null | 210032683 | UKALLR3 |
| 210034951 | 210027597 | 1.52 | null | Curative (C) | 2014-11-23 | 2015-07-06 | ALL Int Guide A/B/C Maint Ph V | N | N | 210032731 | ALL INTERIM GUIDELINES |
| 210034952 | 210012060 | 1.85 | 125.8 | Disease modification (D) | 2013-04-29 | 2014-02-18 | Blinatumomab | Y | N | 210032841 | BLINATUMOMAB |
| 210034953 | 210012067 | 1.77 | 102.6 | Curative (C) | 2013-08-20 | 2013-11-11 | Alemtuzumab(INTRAVENOUS) | N | N | 210032895 | ALEMTUZUMAB |
| 210034954 | 210012072 | 1.64 | 15.4 | Disease modification (D) | 2017-07-28 | 2017-07-28 | Venetoclax | 2 | N | 210032935 | VENETOCLAX |
| 210034955 | 210012085 | 1.53 | 59 | Disease modification (D) | 2017-12-23 | 2018-01-07 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | N | 210032967 | UKALLR3 |
| 210034956 | 210012092 | 1.79 | 95 | Curative (C) | 2019-07-16 | 2019-07-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 210032998 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210034957 | 210012104 | 1.79 | null | Curative (C) | 2013-11-12 | 2013-11-15 | Blinatumomab | Y | N | 210033089 | BLINATUMOMAB |
| 210034958 | 210027626 | 1.57 | 76.9 | Curative (C) | 2018-05-27 | 2018-05-27 | ALL Int Guide A/B/C Maint Ph V | N | N | 210033143 | ALL INTERIM GUIDELINES |
| 210034959 | 210021703 | 1.7 | 69.3 | Curative (C) | 2017-06-14 | 2017-06-14 | AML Interim Guidelines FLAG-Ida | N | N | 210033216 | FLAG + IDARUBICIN |
| 210034960 | 210012134 | 1.2 | 98.1 | Curative (C) | 2014-08-09 | 2014-08-15 | Carboplatin AUC 2 - 5 | N | N | 210033272 | CARBOPLATIN |
| 210034961 | 210012140 | null | 80.6 | Curative (C) | 2014-06-13 | 2014-06-13 | MERCAPTOPURINE + METHOTREXATE | Y | N | 210033299 | MERCAPTOPURINE + METHOTREXATE |
| 210034962 | 210012148 | null | 59 | Curative (C) | 2015-06-03 | 2015-06-10 | CARBOPLATIN | N | N | 210033319 | CARBOPLATIN |
| 210034963 | 210012149 | 1.09 | 71.3 | Curative (C) | 2014-06-03 | 2014-06-05 | FLAG + Idarubicin | 2 | N | 210033321 | FLAG + IDARUBICIN |
| 210034964 | 210012156 | 1.59 | null | Curative (C) | null | 2016-05-03 | CHOP R - 21 days | N | N | 210033375 | CHOP R |
| 210034965 | 210021730 | 1.82 | 57 | Curative (C) | 2014-09-10 | 2015-04-24 | ALL Int GdeC D Int PhIV recon Pasp | N | N | 210033416 | ALL INTENSIFICATION |
| 210034966 | 210027655 | 1.72 | 19.6 | Curative (C) | 2015-06-01 | 2015-06-01 | BLINATUMOMAB | Y | null | 210033486 | BLINATUMOMAB |
| 210034967 | 210012192 | null | 100.4 | Not known (9) | 2018-02-15 | 2018-08-30 | Blinatumomab | N | N | 210033503 | BLINATUMOMAB |
| 210034968 | 210027656 | null | 84.7 | Curative (C) | null | 2016-08-27 | Chlorambucil | Y | N | 210033509 | CHLORAMBUCIL |
| 210034969 | 210021753 | 1.72 | 105.9 | Disease modification (D) | 2016-10-26 | 2017-01-08 | Alemtuzumab | N | N | 210033611 | ALEMTUZUMAB |
| 210034970 | 210021757 | 1.84 | 81.7 | Adjuvant (A) | 2017-11-18 | 2017-12-08 | BLINATUMOMAB | N | N | 210033652 | BLINATUMOMAB |
| 210034971 | 210012225 | 0 | null | Palliative (P) | 2018-01-07 | 2018-02-12 | FLAG + Idarubicin | N | N | 210033656 | FLAG + IDARUBICIN |
| 210034972 | 210021762 | null | 28 | Disease modification (D) | 2015-10-09 | 2015-12-16 | Chlorambucil | N | N | 210033690 | CHLORAMBUCIL |
| 210034973 | 210012231 | null | 84.4 | Curative (C) | null | 2016-09-12 | FLAG + Idarubicin | Y | N | 210033709 | FLAG + IDARUBICIN |
| 210034974 | 210012233 | 1.58 | 66 | Curative (C) | 2015-06-07 | 2015-08-02 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | N | 210033717 | UKALLR3 |
| 210034975 | 210021772 | 1.73 | 80.8 | Curative (C) | 2015-09-13 | 2016-01-09 | CARBOPLATIN | 99 | null | 210033764 | CARBOPLATIN |
| 210034976 | 210021778 | null | 88 | Disease modification (D) | 2015-07-29 | 2015-11-24 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 210033792 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210034977 | 210012269 | 1.72 | 92.4 | Disease modification (D) | null | 2018-07-18 | Chlorambucil | N | N | 210033851 | CHLORAMBUCIL |
| 210034978 | 210012272 | 1.6 | null | Curative (C) | 2017-03-22 | 2017-06-07 | Alemtuzumab(INTRAVENOUS) | N | N | 210033859 | ALEMTUZUMAB |
| 210034979 | 210021792 | 1.79 | 71.4 | Curative (C) | 2015-10-10 | 2016-02-11 | ALL Int Gde A/B DInt PhIV pt1 PAsp | N | N | 210033868 | ALL INTENSIFICATION |
| 210034980 | 210012278 | 0 | 76.3 | Disease modification (D) | 2013-05-09 | 2013-10-23 | Venetoclax | 02 | N | 210033900 | VENETOCLAX |
| 210034981 | 210012293 | 1.8 | 75 | Palliative (P) | 2019-04-01 | 2019-04-11 | Alemtuzumab(INTRAVENOUS) | 02 | N | 210033985 | ALEMTUZUMAB |
| 210034982 | 210012297 | null | 29 | null | 2018-12-14 | 2018-12-16 | Mercaptopurine | N | N | 210034017 | MERCAPTOPURINE |
| 210034983 | 210012301 | 1.56 | 52.5 | Palliative (P) | 2017-07-29 | 2017-07-31 | FLAG + Idarubicin | 02 | N | 210034037 | FLAG + IDARUBICIN |
| 210034984 | 210012317 | 1.81 | 22.8 | Palliative (P) | 2017-09-10 | 2017-09-11 | Carboplatin AUC 2 - 5 | null | N | 210034115 | CARBOPLATIN |
| 210034985 | 210027704 | 1.7 | 79.6 | Curative (C) | 2019-10-19 | 2020-03-13 | FLAG + Idarubicin | Y | N | 210034173 | FLAG + IDARUBICIN |
| 210034986 | 210021831 | 1.74 | 17.6 | Curative (C) | 2018-11-13 | 2018-11-13 | Chlorambucil | N | N | 210034178 | CHLORAMBUCIL |
| 210034987 | 210012340 | 1.77 | 68.1 | Palliative (P) | 2019-03-08 | 2019-03-21 | Venetoclax | N | null | 210034234 | VENETOCLAX |
| 210034988 | 210012350 | 1.61 | 52.3 | Palliative (P) | 2017-12-20 | 2017-12-20 | Blinatumomab | 02 | N | 210034345 | BLINATUMOMAB |
| 210034989 | 210012352 | 1.75 | 95 | Curative (C) | 2016-08-11 | 2017-02-05 | ALL Int GdeC D Int PhIV recon Pasp | null | null | 210034354 | ALL INTENSIFICATION |
| 210034990 | 210012359 | 1.12 | 26.8 | Curative (C) | 2014-01-19 | 2014-09-15 | Carboplatin AUC 2 - 5 | Y | N | 210034384 | CARBOPLATIN |
| 210034991 | 210031301 | null | 75 | Curative (C) | 2013-06-11 | 2013-08-17 | Chlorambucil | N | N | 210034437 | CHLORAMBUCIL |
| 210034992 | 210012372 | null | 65 | Palliative (P) | 2016-03-05 | 2016-03-07 | Carboplatin AUC 6 - 10 | N | N | 210034516 | CARBOPLATIN |
| 210034993 | 210021855 | 0 | 70 | Curative (C) | 2016-09-24 | 2016-09-24 | Chlorambucil | Y | N | 210034567 | CHLORAMBUCIL |
| 210034994 | 210012394 | 1.79 | 44 | Curative (C) | 2017-05-09 | 2017-12-25 | ALL Int Guide A/B/C Maint Ph V | 2 | N | 210034672 | ALL INTERIM GUIDELINES |
| 210034995 | 210012396 | 1.65 | 102.6 | Curative (C) | 2019-08-25 | 2019-08-25 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | 2 | N | 210034702 | UKALLR3 |
| 210034996 | 210021868 | null | 66.4 | Curative (C) | 2017-12-09 | 2017-12-22 | ETOPOSIDE | Y | N | 210034738 | ETOPOSIDE |
| 210034997 | 210012406 | 0 | 28 | Disease modification (D) | 2016-05-21 | 2016-06-03 | Chlorambucil | N | N | 210034764 | CHLORAMBUCIL |
| 210034998 | 210021875 | 1.76 | null | Curative (C) | 2014-05-26 | 2014-05-29 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | 01 | Y | 210034792 | UKALLR3 |